Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051491024> ?p ?o ?g. }
- W2051491024 endingPage "266" @default.
- W2051491024 startingPage "261" @default.
- W2051491024 abstract "Bortezomib combination chemotherapy appears to be active in light chain (AL) amyloidosis with high rates of hematologic and organ response. We report a retrospective evaluation of the clinical outcome of treatment with bortezomib, melphalan, and prednisolone (VMP) as first-line chemotherapy in patients with AL amyloidosis who were ineligible for autologous stem cell transplant. Among the 19 patients included in this study, 90% had two or more involved organs and most of the patients had advanced stage AL amyloidosis (84% with 2004 Mayo Stage III and 92% with 2012 Mayo Stage III or IV). Sixteen (84%) patients had a hematologic response, including seven (37%) with complete response, with time to response of 1–3 months. Cardiac and renal responses were observed in 44% and 33% of patients, respectively. Estimated 2-year survival is 39%, and 5 patients (26%) died during therapy. The common grade 3–4 adverse events were thrombocytopenia, diarrhea and pneumonia. A once-weekly bortezomib is more feasible than twice-weekly regimen. Our results suggest that triplet regimen of VMP appears to be an effective regimen in advanced AL amyloidosis ,but benefits in the patients with multi-organ dysfunction remain to be proven." @default.
- W2051491024 created "2016-06-24" @default.
- W2051491024 creator A5000179774 @default.
- W2051491024 creator A5004166441 @default.
- W2051491024 creator A5006618457 @default.
- W2051491024 creator A5022259689 @default.
- W2051491024 creator A5026928887 @default.
- W2051491024 creator A5045574858 @default.
- W2051491024 creator A5046322834 @default.
- W2051491024 creator A5062157181 @default.
- W2051491024 creator A5067013399 @default.
- W2051491024 creator A5075444776 @default.
- W2051491024 creator A5075462954 @default.
- W2051491024 creator A5088244081 @default.
- W2051491024 date "2014-09-24" @default.
- W2051491024 modified "2023-10-18" @default.
- W2051491024 title "Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis" @default.
- W2051491024 cites W1969551915 @default.
- W2051491024 cites W1973853538 @default.
- W2051491024 cites W1994036267 @default.
- W2051491024 cites W1995859732 @default.
- W2051491024 cites W1999473831 @default.
- W2051491024 cites W2001594121 @default.
- W2051491024 cites W2007335884 @default.
- W2051491024 cites W2033793452 @default.
- W2051491024 cites W2039607042 @default.
- W2051491024 cites W2058789242 @default.
- W2051491024 cites W206392377 @default.
- W2051491024 cites W2070335603 @default.
- W2051491024 cites W2075174733 @default.
- W2051491024 cites W2077918440 @default.
- W2051491024 cites W2096207943 @default.
- W2051491024 cites W2098093182 @default.
- W2051491024 cites W2107403553 @default.
- W2051491024 cites W2111080788 @default.
- W2051491024 cites W2131259241 @default.
- W2051491024 cites W2161231801 @default.
- W2051491024 cites W2161648900 @default.
- W2051491024 cites W2164807675 @default.
- W2051491024 cites W2165897928 @default.
- W2051491024 cites W2169183166 @default.
- W2051491024 cites W2171033052 @default.
- W2051491024 cites W2171783170 @default.
- W2051491024 cites W2319723388 @default.
- W2051491024 doi "https://doi.org/10.3109/13506129.2014.960560" @default.
- W2051491024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25248716" @default.
- W2051491024 hasPublicationYear "2014" @default.
- W2051491024 type Work @default.
- W2051491024 sameAs 2051491024 @default.
- W2051491024 citedByCount "21" @default.
- W2051491024 countsByYear W20514910242015 @default.
- W2051491024 countsByYear W20514910242016 @default.
- W2051491024 countsByYear W20514910242017 @default.
- W2051491024 countsByYear W20514910242018 @default.
- W2051491024 countsByYear W20514910242019 @default.
- W2051491024 countsByYear W20514910242020 @default.
- W2051491024 countsByYear W20514910242021 @default.
- W2051491024 countsByYear W20514910242022 @default.
- W2051491024 countsByYear W20514910242023 @default.
- W2051491024 crossrefType "journal-article" @default.
- W2051491024 hasAuthorship W2051491024A5000179774 @default.
- W2051491024 hasAuthorship W2051491024A5004166441 @default.
- W2051491024 hasAuthorship W2051491024A5006618457 @default.
- W2051491024 hasAuthorship W2051491024A5022259689 @default.
- W2051491024 hasAuthorship W2051491024A5026928887 @default.
- W2051491024 hasAuthorship W2051491024A5045574858 @default.
- W2051491024 hasAuthorship W2051491024A5046322834 @default.
- W2051491024 hasAuthorship W2051491024A5062157181 @default.
- W2051491024 hasAuthorship W2051491024A5067013399 @default.
- W2051491024 hasAuthorship W2051491024A5075444776 @default.
- W2051491024 hasAuthorship W2051491024A5075462954 @default.
- W2051491024 hasAuthorship W2051491024A5088244081 @default.
- W2051491024 hasConcept C126322002 @default.
- W2051491024 hasConcept C141071460 @default.
- W2051491024 hasConcept C143998085 @default.
- W2051491024 hasConcept C159654299 @default.
- W2051491024 hasConcept C203014093 @default.
- W2051491024 hasConcept C2776364478 @default.
- W2051491024 hasConcept C2776694085 @default.
- W2051491024 hasConcept C2776715498 @default.
- W2051491024 hasConcept C2776755627 @default.
- W2051491024 hasConcept C2777478702 @default.
- W2051491024 hasConcept C2778336483 @default.
- W2051491024 hasConcept C2778684742 @default.
- W2051491024 hasConcept C2779551797 @default.
- W2051491024 hasConcept C2779951007 @default.
- W2051491024 hasConcept C2781413609 @default.
- W2051491024 hasConcept C36394416 @default.
- W2051491024 hasConcept C71924100 @default.
- W2051491024 hasConcept C90924648 @default.
- W2051491024 hasConceptScore W2051491024C126322002 @default.
- W2051491024 hasConceptScore W2051491024C141071460 @default.
- W2051491024 hasConceptScore W2051491024C143998085 @default.
- W2051491024 hasConceptScore W2051491024C159654299 @default.
- W2051491024 hasConceptScore W2051491024C203014093 @default.
- W2051491024 hasConceptScore W2051491024C2776364478 @default.
- W2051491024 hasConceptScore W2051491024C2776694085 @default.
- W2051491024 hasConceptScore W2051491024C2776715498 @default.